Loading cancer entity…
Loading cancer entity…
Clinical trials
341 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05080621 | Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST) | withdrawn | Phase 1 / Phase 2 | 0 | Deciphera Pharmaceuticals, LLCINDUSTRY | 0 | Jan 5, 2022 | clinicaltrials |
| NCT02268435 | Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors | withdrawn | Phase 1 | 0 | Asan Medical CenterOTHER | 0 | Aug 4, 2015 | clinicaltrials |
Showing 1–2 of 2 studies
Data updated 22 days agoSource updated Jan 5, 2022source: clinicaltrials